Polaris Quantum Biotech (Polarisqb) is a quantum software company that uses quantum computing and artificial intelligence to process, evaluate and identify drug lead molecules 10,000 times faster than alternative solutions. Allosteric Bioscience is a company formed in 2021 to utilize quantum computing, artificial intelligence, and other sciences to create improved treatments for aging, longevity, and aging related diseases. The goal of the partnership will be to leverage their respective technologies to create an inhibitor of a key protein involved in human aging and longevity. Polarisqb will be using its Tachyontm drug design platform and Allosteric Bioscience will be using its two aging platforms: “ALT” – Aging Longevity Targets and “ALM” – Aging Longevity Modulators for this research. As part of the agreement Allosteric Bioscience will also be making an equity investment in Polarisqb. For more information about this partnership, you can view a news release available here.
February 6, 2022
